SecSonar.com

Incannex Healthcare Limited (IXHL)

Incannex Healthcare Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Incannex Healthcare Limited (IXHL) is a Drug Manufacturers - Specialty & Generic company based in AU with a market capitalization of $39.6M. Free cash flow was negative at -$12.5M. This page tracks IXHL's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

AU · 9 employees · IPO Mar 2, 2022

Valuation

Valuation & price

$3.37 · as of May 26, 2026 · -93.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.96

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$32.10$17.41$2.71Jul 25Dec 25Jul 26Jul 7, 25$6.31Jul 9, 25$6.63Jul 11, 25$6.61Jul 15, 25$10.20Jul 17, 25$11.10Jul 21, 25$24.60Jul 23, 25$30.30Jul 25, 25$31.50Jul 29, 25$32.10Jul 31, 25$17.55Aug 4, 25$13.34Aug 6, 25$10.35Aug 11, 25$13.40Aug 13, 25$12.00Aug 15, 25$11.40Aug 19, 25$11.46Aug 21, 25$13.73Aug 25, 25$22.22Aug 27, 25$20.11Aug 29, 25$19.77Sep 3, 25$18.72Sep 5, 25$15.75Sep 9, 25$16.36Sep 11, 25$15.90Sep 16, 25$16.19Sep 18, 25$16.20Sep 22, 25$15.90Sep 24, 25$18.36Sep 26, 25$17.85Sep 30, 25$13.93Oct 2, 25$13.80Oct 6, 25$13.34Oct 8, 25$12.97Oct 10, 25$11.75Oct 14, 25$11.43Oct 16, 25$10.50Oct 21, 25$10.71Oct 23, 25$10.23Oct 27, 25$10.51Oct 29, 25$10.28Oct 31, 25$11.31Nov 4, 25$10.18Nov 6, 25$10.92Nov 10, 25$10.87Nov 12, 25$11.18Nov 14, 25$10.57Nov 18, 25$10.49Nov 20, 25$9.96Nov 25, 25$10.00Nov 28, 25$10.81Dec 2, 25$11.90Dec 4, 25$14.36Dec 8, 25$12.99Dec 10, 25$12.38Dec 12, 25$12.69Dec 16, 25$12.55Dec 18, 25$11.91Dec 22, 25$13.28Dec 24, 25$12.32Dec 29, 25$11.10Jan 2, 26$11.70Jan 6, 26$12.17Jan 8, 26$11.94Jan 12, 26$11.72Jan 14, 26$11.66Jan 16, 26$11.31Jan 21, 26$10.70Jan 23, 26$10.32Jan 27, 26$9.42Jan 29, 26$9.35Feb 2, 26$8.87Feb 4, 26$8.55Feb 9, 26$8.34Feb 11, 26$8.37Feb 13, 26$8.07Feb 18, 26$7.80Feb 20, 26$8.40Feb 24, 26$8.22Feb 26, 26$5.01Mar 2, 26$3.82Mar 4, 26$3.96Mar 6, 26$3.90Mar 10, 26$5.01Mar 12, 26$3.08Mar 17, 26$3.31Mar 19, 26$3.10Mar 23, 26$3.07Mar 25, 26$3.22Mar 27, 26$3.24Mar 31, 26$3.00Apr 2, 26$2.90Apr 7, 26$2.71Apr 9, 26$2.88Apr 13, 26$3.55Apr 15, 26$3.63Apr 17, 26$3.65Apr 22, 26$4.09Apr 24, 26$4.03Apr 28, 26$4.08Apr 30, 26$4.39May 4, 26$4.62May 6, 26$4.91May 8, 26$4.58May 12, 26$3.90May 14, 26$3.88May 18, 26$3.79May 20, 26$3.71May 22, 26$3.52May 28, 26$3.55Jun 1, 26$3.25Jun 3, 26$3.06Jun 5, 26$2.92Jun 9, 26$3.67Jun 11, 26$3.82Jun 15, 26$3.67Jun 17, 26$3.70Jun 22, 26$3.25Jun 24, 26$3.25Jun 26, 26$3.42Jul 2, 26$3.97
$2.5652-week range$48.90
Loading valuation history…

Fundamentals

Key fundamentals

$39.6M

Market cap

—

Revenue growth (YoY)

-186.1%

Gross margin

-$12.5M

Free cash flow (USD)

-$14.8M

Net debt

Net cash position

-78.7%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$89.4KFY 2017$283.0KFY 2018$1.0MFY 2019$1.2MFY 2020$599.7KFY 2021$1.9MFY 2022$785.2KFY 2023$0.00FY 2024$12.0KFY 2025$86.0K
$89.4K$86K

Free cash flow by year

2016 → 2025

FY 2016$-668.6KFY 2017$-2.7MFY 2018$-2.9MFY 2019$-2.2MFY 2020$-3.9MFY 2021$-6.9MFY 2022$-12.9MFY 2023$-16.7MFY 2024$-16.1MFY 2025$-12.5M
-$668.6K-$12.5M

Gross margin by year

2021 → 2025

FY 202151.9%FY 202299.2%FY 2024100.0%FY 2025-186.1%
51.9%-186.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 15, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventPatent GrantJun 25, 2026Filing
  • 8-K eventR&D Tax Incentive RefundJun 10, 2026Filing
  • 8-K eventResearch Coverage InitiatedJun 9, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventClinical Study CommencementMay 14, 2026Filing
  • 8-K eventAward AnnouncementMay 12, 2026Filing
  • 8-K eventRegulatory DisclosureApr 22, 2026Filing

Questions

Frequently asked questions

What is Incannex Healthcare Limited's market cap?

Incannex Healthcare Limited (IXHL) has a market capitalization of $39.6M.

What is IXHL's P/E ratio?

A meaningful P/E ratio is not available for IXHL — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is IXHL's price-to-book (P/B) ratio?

IXHL trades at 2.96 times book value per share.

Are insiders buying IXHL stock?

SEC Form 4 filings show no open-market insider buys at Incannex Healthcare Limited in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

ZYBT

Zhengye Biotechnology Holding Limited

$39.4M

SCYX

SCYNEXIS, Inc.

$37.7M

RMTI

Rockwell Medical, Inc.

$29.3M

TXMD

TherapeuticsMD, Inc.

$24.2M

OPTH

Optimi Health Corp.

$19.6M

AYTU

Aytu BioPharma, Inc.

$17.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.